Sector: Health Care
Director information for BRUKER CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Adelene Q. Perkins | Director | 66 | ["Chief Executive Officer of Infinity Pharmaceuticals, Inc. from 2010-2023","Chair of Infinity’s Board of Directors from 2012-2023","Vice President of Business and Corporate Development of TransForm Pharmaceuticals, Inc.","General Manager of the DiscoverEase business unit at Genetics Institute","CEO of MetaMorphix","Experience at Bain & Company","Served on various for-profit and not-for-profit boards","Holds a Master of Business Administration from Harvard Business School","Bachelor of Science degree in chemical engineering from Villanova University","Over 35 years of international business and corporate strategy experience"] | ["Finance and Real Estate","Naming","Research and Education","Audit and Compliance","Nominating and Governance"] | 2026 |
| Bonnie H. Anderson | CEO and Chairman | 68 | ["CEO and Chairman of PinkDx, Inc.","Co-founded Veracyte in 2008","Chair of Veracyte's Board of Directors from 2016 to 2023","Served as CEO of Veracyte from February 2008 to May 2021","Served as President at Veracyte from August 2013 to February 2017","Independent strategic consultant from 2006 to 2008","Vice President at Beckman Coulter, Inc.","Board member of DNA Script","President of the Coalition for 21st Century Medicine","Board of Trustees of the Keck Graduate Institute"] | ["Compensation Committee","Nominating & Governance Committee"] | 2026 |
| Burkhard A. Prause, Ph.D. | President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc. | 59 | ["Ph.D. in Physics from the University of Notre Dame","Director of Hydrostatic Extrusions Ltd.","Managing Director of Bruker EAS GmbH","Managing Director of Bruker HTS GmbH","Senior staff scientist at the Max-Planck Institute"] | ["Director of CCAS","Former Chairman of ivSupra"] | 2026 |
| Falko Busse, Ph.D. | President, Bruker BioSpin Group; President of the Bruker BioSpin Group | 59 | ["Ph.D. in Physics from Rheinische Friedrich-Wilhelms-Universität Bonn","Global operations management experience","Previous roles at Philips Healthcare including General Manager Radiology Solutions and General Manager MR-Therapy"] | [] | 2026 |
| Frank H. Laukien, Ph.D. | Chairman, President and Chief Executive Officer | 66 | ["Bachelor of Science degree in physics from MIT","Ph.D. in chemical physics from Harvard","Chairman of the Board","Chief Executive Officer","Governing trustee of the Dana-Farber Cancer Institute","Senator of acatech, the German National Academy of Science and Engineering","Visiting Scholar at Harvard University","Experience in organizational management, strategic planning, finance, global business development, and life science tools and diagnostics markets"] | [] | 2026 |
| Hermann F. Requardt, Ph.D. | Director | 71 | ["Independent strategic advisor to European life science and healthcare technology companies","Former CEO of the healthcare division of Siemens AG","Former Chief Technology Officer of Siemens AG","Member of the Siemens AG Managing Board","Former global responsibility for the magnetic resonance business unit","Honorary Professor of Physics at the University of Frankfurt","Experience in management and strategic planning of life sciences companies"] | ["Compensation Committee"] | 2026 |
| John A. Ornell | Director | 68 | ["Retired from Waters Corporation","Vice President, Finance and Administration","Chief Financial Officer","Responsible for information technology, investor relations, and TA Instruments Division","Operational and financial leadership roles","Bachelor of Science in Business Administration","Bachelor of Arts in Economics","Master of Business Administration","Certified Management Accountant","Certified Public Accountant"] | ["Audit Committee"] | 2026 |
| John J. (Jack) Phillips | Director | 60 | ["President & CEO of Accelerate Diagnostics from 2020-2025","President & CEO of Roche Diagnostics North America from 2010-2020","Senior VP and General Manager, North America, for Ventana Medical Systems from 1999-2010","B.S. in Marketing from Northern Kentucky University"] | ["Compensation Committee"] | 2026 |
| Juergen W. Srega | President, Bruker CALID Group and Bruker Daltonics Division; President of the Bruker CALID Group | 71 | ["President of the Bruker CALID Group since January 2013","Managing Director of Bruker Daltonik GmbH","Various senior management roles at Thermo Fisher Scientific Inc. since 1996","Led significant operating divisions at Thermo","Bachelor of Arts degree in Finance from Nord Akademie in Hamburg, Germany","Bachelor of Arts degree in Engineering from Karlsruhe University of Applied Science in Karlsruhe, Germany"] | [] | 2026 |
| Laura A. Francis | Chief Executive Officer and Board Member | 59 | ["Chief Operating Officer at SI-BONE","Chief Financial Officer at SI-BONE","Vice President of Finance, Chief Financial Officer, and Treasurer at Promega Corporation","Chief Operating Officer and Chief Financial Officer at Nutra-Park Inc.","Chief Financial Officer and Treasurer at Bruker","Engagement Manager at McKinsey & Company","Audit Manager at Coopers & Lybrand","Audit committee chair and compensation committee member at Shockwave Medical"] | ["Audit Committee"] | 2026 |
| Richard A. Packer | Vice Presidential Executive Officer | 68 | ["Vice Presidential Executive Officer of Asahi Kasei Corporation","Former leader of Asahi Kasei’s healthcare business unit","Former non-executive Chairman of ZOLL Medical Corporation","Former Chief Executive Officer and director of ZOLL","Extensive financial, operations and management experience in the medical devices industry","Experience in corporate governance, strategic planning, and public company compensation matters"] | ["Nominating & Governance Committee"] | 2026 |
| Robert J. Rosenthal, Ph.D. | Director | 69 | ["Chief Executive Officer of Taconic Biosciences, Inc.","President and Chief Executive Officer of IMI Intelligent Medical Implants, AG","President and Chief Executive Officer of Magellan Biosciences, Inc.","Senior management positions at Perkin Elmer Inc. and Thermo Fisher Scientific, Inc.","Director of Safeguard Scientifics, Inc.","Chairman of Board of Directors of Safeguard Scientifics, Inc. since May 2016","Director of Galvanic Applied Sciences, Inc.","Ph.D. from Emory University","Master of Science degree from the State University of New York"] | ["Audit Committee","Compensation Committee"] | 2026 |
| Thierry L. Bernard | Chief Executive Officer | 61 | ["Chief Executive Officer of QIAGEN since March 2020","Member of QIAGEN's Managing Board since 2021","Held roles of increasing responsibility during 15 years with bioMérieux SA","Corporate Vice President, Global Commercial Operations, Investor Relations in the Greater China Region","Senior management roles in several leading international companies","Earned degrees and certifications from Sciences Po Paris, the London School of Economics, the College of Europe, Harvard Business School, and Centro de Comercio Exterior de Barcelona","Appointed Conseiller du Commerce Extérieur by the French government"] | ["AdvaMedDx Board of Directors"] | 2026 |
| William A. Linton, Ph.D. | Chairman, President and Chief Executive Officer | 78 | ["extensive executive experience","international operations management","technical expertise in the life sciences industry","significant experience in strategic planning","corporate governance","executive compensation matters"] | ["Nominating & Governance Committee"] | 2026 |
